4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-004725
Chief Financial Officer sold 2,500 shares at $241.86 ($604,650)
- Chief Financial Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sandercock Brett · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-10 | Exercise or conversion : show line 1 in the form | +2,500 | $57.76 | $144,400 | 108,854 | D |
| 2022-02-10 | Sale : show line 2 in the form | −2,500 | $241.86 | $604,650 | 106,354 | D |
| Open-market sales · 2,500 sh · avg $241.86 · $604,650 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-10 | Exercise or conversion : show line 3 in the form ResMed Common Stock Options | −2,500 | 15,000 | D |
Loading xslF345X03/form4.xml…